Oncology Business Management | Specialty

The OncLive Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.

Dr. Ewer Discusses Supportive Care

July 24th 2012

Dr. Michael S. Ewer, from The University of Texas MD Anderson Cancer Center, on Supportive Care

FDA Approves Everolimus for Advanced Breast Cancer

July 23rd 2012

The FDA has approved everolimus for treating patients with hormone receptor-positive, HER2 negative breast cancer, when given in combination with the aromatase inhibitor exemestane.

Oncology Nurse Staffing Is Variable and Multifactorial

July 19th 2012

Nurse staffing varies from institution to institution, depending on many factors, both internal and external. To gain a better understanding of nurse staffing, ratios of nurses to patients, and productivity, a survey was sent to ONS members.

Payer Management of Oncology Gets Serious

July 16th 2012

Health plans continue to seek methods to curtail cancer costs.

Reimbursement: The Good, The Bad, and The Ugly

July 12th 2012

Prior approval improves chances of being reimbursed, increases practice costs, and can delay treatment.

Case-Based Discussion: Sequencing Prostate Cancer Therapy

July 3rd 2012

Case-based discussion on sequencing prostate cancer therapies for a 72-year-old man with a metastatic adenocarcinoma with small-cell components, a PSA score of 80, and a Gleason score of 10.

Oncology Leaders Praise Health Law Ruling-With Caveats

June 28th 2012

Leaders in the oncology care and research communities largely applauded the US Supreme Court ruling Thursday that upholds the Affordable Care Act.

Paclitaxel Shortage May Add Millions to Cost of Ovarian Cancer Care

June 27th 2012

A chronic shortage of the most commonly used taxane for ovarian cancer would add almost $9 million a month to the cost of care if half of newly diagnosed cases were affected.

Urology Under Attack

June 21st 2012

As we head into the sweltering days of summer, physicians-and urologists in particular-face a series of challenges that can potentially impact the way we practice and how we manage our patients.

Dr. Schilsky Summarizes the Oncology Drug Shortage

June 21st 2012

Dr. Richard Schilsky, from the University of Chicago, Summarizes the Recent Oncology Drug Shortage.

Health Insurance Gaps

June 20th 2012

2011 survey finds 25% of adults experienced a gap in health insurance last year.

Dr. Ryan Discusses Sequencing Prostate Cancer Therapies

June 18th 2012

Dr. Charles Ryan, from UCSF Helen Diller Family Comprehensive Cancer Center, Discusses Sequencing Castration-Resistant Prostate Cancer Therapies.

The Changing World of Oncology Practice

June 18th 2012

Economic pressures are forcing many oncologists to leave small private practices for larger institutional organizations.

There and Back…

June 15th 2012

One of my teachers in medical school was fond of saying, "Internal medicine isn't sexy." Hematology/ oncology is no exception to this rule. Certainly, it is not as glamorous as cardiology or as hands-on as gastroenterology.

Finding Time: A Day in the Life of an Academic Oncologist

June 15th 2012

We all have to balance competing demands on our time. But as an academic oncologist, I have to keep a foot in 2 worlds, research and clinical, while still keeping my balance.

From a Distance: Managing Side Effects in Outpatients

June 12th 2012

Checking in with patients can bring positive results, since oncology nurses are able to offer interventions for most symptoms of cancer treatment. Includes an in-depth look at telephone triage.

IPCC Case-Based Discussion: How Should We Sequence Therapy?

June 12th 2012

Three case studies focused on how best to sequence therapy in prostate cancer were presented by Daniel P. Petrylak, MD, and discussed by a panel that included Robert Dreicer, MD, and Oliver Sartor, MD.

Unraveling the Complexity of Drug Shortages: Grim Reality Is a Bitter Pill to Swallow

June 7th 2012

An interview with ASCO President Michael P. Link, MD, discussing the impact of oncology drug shortages.

FDA and Industry Collaborating to Prevent Cancer Drug Shortages

June 5th 2012

Drug manufacturers are working with the FDA to report anticipated shortages earlier and ensure alternative sources of needed drugs are available.

Dr. Gomella on the Impact of the New USPSTF PSA Rating

May 22nd 2012

Dr. Leonard Gomella, form the Jefferson Kimmel Cancer Center, on the Impact of the New USPSTF PSA Rating.